ZA200903566B - Isosorbide mononitrate derivatives for the treatment of ocular hypertension - Google Patents

Isosorbide mononitrate derivatives for the treatment of ocular hypertension

Info

Publication number
ZA200903566B
ZA200903566B ZA200903566A ZA200903566A ZA200903566B ZA 200903566 B ZA200903566 B ZA 200903566B ZA 200903566 A ZA200903566 A ZA 200903566A ZA 200903566 A ZA200903566 A ZA 200903566A ZA 200903566 B ZA200903566 B ZA 200903566B
Authority
ZA
South Africa
Prior art keywords
treatment
ocular hypertension
isosorbide mononitrate
mononitrate derivatives
derivatives
Prior art date
Application number
ZA200903566A
Other languages
English (en)
Inventor
Moliner Jose Repolles
Coy Francisco Pubill
Mancini Marisabel Mourelle
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38043051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903566(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of ZA200903566B publication Critical patent/ZA200903566B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200903566A 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of ocular hypertension ZA200903566B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06380338A EP1941876A1 (fr) 2006-12-28 2006-12-28 Derivés du mononitrite de l'isosorbide destinées au traitement de l'inflammation et l'hypertension oculaire

Publications (1)

Publication Number Publication Date
ZA200903566B true ZA200903566B (en) 2010-08-25

Family

ID=38043051

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200903567A ZA200903567B (en) 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of intestinal disorders
ZA200903566A ZA200903566B (en) 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of ocular hypertension

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200903567A ZA200903567B (en) 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of intestinal disorders

Country Status (21)

Country Link
US (1) US20080161389A1 (fr)
EP (3) EP1941876A1 (fr)
JP (2) JP2010514733A (fr)
KR (2) KR20090112673A (fr)
CN (2) CN101600425A (fr)
AR (1) AR064543A1 (fr)
AT (2) ATE484279T1 (fr)
AU (2) AU2007341218B2 (fr)
BR (2) BRPI0720663A2 (fr)
CA (2) CA2674144A1 (fr)
CL (2) CL2007003836A1 (fr)
DE (2) DE602007009877D1 (fr)
ES (3) ES2324130B1 (fr)
IL (2) IL198912A0 (fr)
MX (2) MX2009007038A (fr)
NO (2) NO20092763L (fr)
PL (2) PL2124930T3 (fr)
RU (2) RU2009128970A (fr)
UY (1) UY30847A1 (fr)
WO (2) WO2008080939A1 (fr)
ZA (2) ZA200903567B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149577B1 (fr) * 2008-07-22 2011-04-27 Lacer, S.A. Nouveau procédé stéréospécifique pour la préparation de composés de dioxa-bicyclooctane
EP2149576A1 (fr) * 2008-07-22 2010-02-03 Lacer, S.A. Nitrates d'isosorbide ayant une activité vasodilatatrice
EP2177216A1 (fr) * 2008-10-13 2010-04-21 Lacer, S.A. Utilisation de dérivés de mononitrate de dianhydrohexite comme agents de cicatrisation
WO2010055138A1 (fr) * 2008-11-14 2010-05-20 Lacer, S.A. Nouveau procédé stéréospécifique pour la préparation de composés de dioxabicyclooctane
EP2199294A1 (fr) * 2008-12-19 2010-06-23 Lacer, S.A. Nouveau procédé stéréospécifique pour la préparation de composé de nitrate de dioxa bicyclooctane
DK2515899T3 (en) * 2009-12-23 2016-08-15 Arca Biopharma Inc METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
US20160016969A1 (en) * 2013-03-05 2016-01-21 Archer Daniels Midland Company Isohexide monotriflates and process for synthesis thereof
WO2018224419A1 (fr) 2017-06-06 2018-12-13 Nicox S.A. Dérivés d'isomannide donneurs d'oxyde nitrique

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739689C2 (de) * 1977-09-02 1986-10-16 Euratom Thermische Wärmepumpe
JPS60149521A (ja) * 1984-01-18 1985-08-07 Eisai Co Ltd 高眼圧・緑内障治療・予防用点眼剤
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5925342A (en) * 1996-11-13 1999-07-20 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB9720797D0 (en) * 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20040077664A1 (en) * 2001-01-31 2004-04-22 Hans-Michael Eggenweiler Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
AU2003222049B2 (en) * 2002-03-21 2007-05-31 Cayman Chemical Company, Incorporated Prostaglandin F2 alpha analogs in combination with antimicrobials for treating glaucoma
JP2007504807A (ja) * 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

Also Published As

Publication number Publication date
WO2008080939A1 (fr) 2008-07-10
DE602007007523D1 (de) 2010-08-12
AU2007341218A1 (en) 2008-07-10
AR064543A1 (es) 2009-04-08
CL2007003836A1 (es) 2008-07-11
MX2009007038A (es) 2009-08-25
CN101600426A (zh) 2009-12-09
JP2010514733A (ja) 2010-05-06
DE602007009877D1 (de) 2010-11-25
UY30847A1 (es) 2008-05-31
MX2009007040A (es) 2009-08-25
US20080161389A1 (en) 2008-07-03
EP2124930B1 (fr) 2010-10-13
RU2009128970A (ru) 2011-02-10
ATE484279T1 (de) 2010-10-15
BRPI0720664A2 (pt) 2014-01-14
IL198941A0 (en) 2010-02-17
ATE472324T1 (de) 2010-07-15
CN101600425A (zh) 2009-12-09
ES2354317T3 (es) 2011-03-14
ZA200903567B (en) 2010-08-25
EP2124930A1 (fr) 2009-12-02
NO20092764L (no) 2009-07-27
EP1941876A1 (fr) 2008-07-09
JP2010514734A (ja) 2010-05-06
EP2114398B1 (fr) 2010-06-30
CA2674550A1 (fr) 2008-07-10
NO20092763L (no) 2009-07-27
KR20100100584A (ko) 2010-09-15
BRPI0720663A2 (pt) 2014-01-14
KR20090112673A (ko) 2009-10-28
CN101600426B (zh) 2012-07-25
RU2009128968A (ru) 2011-02-10
AU2007341289A1 (en) 2008-07-10
ES2324130B1 (es) 2010-03-22
CL2007003837A1 (es) 2008-07-11
PL2124930T3 (pl) 2011-04-29
ES2348314T3 (es) 2010-12-02
CA2674144A1 (fr) 2008-07-10
AU2007341289B2 (en) 2010-08-26
AU2007341218B2 (en) 2010-09-09
ES2324130A1 (es) 2009-07-30
IL198912A0 (en) 2010-02-17
EP2114398A1 (fr) 2009-11-11
PL2114398T3 (pl) 2010-11-30
WO2008080955A1 (fr) 2008-07-10

Similar Documents

Publication Publication Date Title
ZA200806510B (en) Heterobicyclic sulfonamide derivatives for the treatment of diabetes
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
SI1802579T1 (sl) Derivati 3-arilaminopiridina
IL198941A0 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
ZA200706791B (en) Isoxazole combretasin derivatives for the treatment of disorders
IL178100A0 (en) 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
HK1130208A1 (en) Alpha-msh derivatives for the treatment of photodermatoses -msh
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
IL175517A0 (en) Processes for preparation of ziprasidone
IL194773A0 (en) New approach to treat intraocular hypertension
ZA200805159B (en) Imidazole derivatives for the treatment of gastrointestinal disorders
EP1750698A4 (fr) Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
IL188787A (en) Preparations for the treatment of diabetic eye complications
PL1879585T3 (pl) Zastosowanie pochodnych pirymidyloaminobenzamidowych do leczenia mastocytozy układowej
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP2032130A4 (fr) Compositions ophtalmiques pour traiter une hypertension oculaire
HK1119676A1 (en) Processes for the preparation of cyclopropyl-amide derivatives
IL189928A0 (en) Thiophene derivatives for the treatment of diabetes
ZA200706084B (en) RNAI-mediated inhibition of ocular hypertension targets
ZA200805601B (en) RNAI-mediated inhibition of IGF1R for treatment of ocular angiogenesis
EP2056811B8 (fr) Traitement à base de modafinil contre l'éjaculation précoce
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IL191552A0 (en) Succinimide derivatives as ocular hypotensive agents